Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Gemma BrueraAntonio GiulianiLucia RomanoAlessandro ChiomintoAlessandra Di SibioStefania MastropietroPierluigi CosenzaEnrico RicevutoMario SchietromaFrancesco Carleinull nullPublished in: BMC cancer (2019)
This case report of a locally advanced rectal NEC with an unusual subcutaneous metastasis deserves further investigation of triplet chemotherapy-based intensive regimens in metastatic GEP NEC.